Genomics Biosci &Tech Co Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomics Biosci &Tech Co Ltd with three other
companies in this sector in Taiwan:
Medigen Biotechnology Corporation
sales of 399.89 million Taiwanese Dollars [US$13.55 million]
of which 81%
was Drug Discovery),
Welgene Biotech Co Ltd
(278.30 million Taiwanese Dollars [US$9.43 million]
Sofiva Genomics Co Ltd
(383.95 million Taiwanese Dollars [US$13.01 million]
During the year ended December of 2016, sales at
Genomics Biosci &Tech Co Ltd were 375.77 million Taiwanese Dollars (US$12.73 million).
decrease of 6.2%
versus 2015, when the company's sales were 400.55 million Taiwanese Dollars.